Rivoceranib
Rivoceranib Uses, Dosage, Side Effects, Food Interaction and all others data.
Rivoceranib is under investigation in clinical trial NCT02726854 (Apatinib as Second-line Treatment of Advanced Pancreatic Cancer).
| Trade Name | Rivoceranib |
| Generic | Rivoceranib |
| Rivoceranib Other Names | APATINIB, Rivoceranib |
| Type | |
| Formula | C24H23N5O |
| Weight | Average: 397.482 Monoisotopic: 397.190260381 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Rivoceranib
